Client News
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments
VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News
The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl.
Aquent mobilizes for social justice
Demand Science Announces 6th Consecutive Year of Double-Digit Revenue Growth and Expansion of Leadership Team as Company Positions for 2021 Acceleration
Company’s Organic Revenue Growth Has Fueled 48% CAGR from 2014 through 2020, New Members of Exec Team Include Chief Data Officer from Google and DataFoundry, President of PureB2B Division, and GM for its U.S. Analytics Business
DANVERS, Mass., December 16, 2020 […]
MCRC Newsletters
Client News
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
CANTON, Mass., January 11, 2021 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today [...]
Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments
Dynasil Corporation of America ("Dynasil" or the "Company"), a leading developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for homeland security, medical and industrial markets, today announces that it has appointed [...]
VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News
The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl. Read more: https://pulmonaryhypertensionnews.com/2020/03/25/covid-19-patient-with-ph-treated-with-ino-via-genosyl-vero-biotech-announces/
Aquent mobilizes for social justice
Company, staff, talent, and clients donate to NAACP Legal Defense and Educational Fund. In the wake of the killings of George Floyd, Breonna Taylor, and too many others, Aquent committed to donating $20,000 to the NAACP Legal [...]
Demand Science Announces 6th Consecutive Year of Double-Digit Revenue Growth and Expansion of Leadership Team as Company Positions for 2021 Acceleration
Company's Organic Revenue Growth Has Fueled 48% CAGR from 2014 through 2020, New Members of Exec Team Include Chief Data Officer from Google and DataFoundry, President of PureB2B Division, and GM for its U.S. Analytics Business DANVERS, Mass., [...]